Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;74(9):1649-1657.
doi: 10.1007/s00018-016-2425-5. Epub 2016 Nov 26.

Wnt signaling and cellular metabolism in osteoblasts

Affiliations
Review

Wnt signaling and cellular metabolism in osteoblasts

Courtney M Karner et al. Cell Mol Life Sci. 2017 May.

Abstract

The adult human skeleton is a multifunctional organ undergoing continuous remodeling. Homeostasis of bone mass in a healthy adult requires an exquisite balance between bone resorption by osteoclasts and bone formation by osteoblasts; disturbance of such balance is the root cause for various bone disorders including osteoporosis. To develop effective and safe therapeutics to modulate bone formation, it is essential to elucidate the molecular mechanisms governing osteoblast differentiation and activity. Due to their specialized function in collagen synthesis and secretion, osteoblasts are expected to consume large amounts of nutrients. However, studies of bioenergetics and building blocks in osteoblasts have been lagging behind those of growth factors and transcription factors. Genetic studies in both humans and mice over the past 15 years have established Wnt signaling as a critical mechanism for stimulating osteoblast differentiation and activity. Importantly, recent studies have uncovered that Wnt signaling directly reprograms cellular metabolism by stimulating aerobic glycolysis, glutamine catabolism as well as fatty acid oxidation in osteoblast-lineage cells. Such findings therefore reveal an important regulatory axis between bone anabolic signals and cellular bioenergetics. A comprehensive understanding of osteoblast metabolism and its regulation is likely to reveal molecular targets for novel bone therapies.

Keywords: Bone; Fatty acids; Glucose; Glutamine; Metabolism; Osteoblast; Wnt; mTORC1; mTORC2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Wnt signaling promotes aerobic glycolysis through mTORC2 activation. Wnt signaling through Frizzled (Fz) and Lrp5/6 induces mTORC2 activity downstream of PI3K-Rac1 signaling whereas mTORC2 activation acutely increases the protein abundance of metabolic enzymes (in red) without changing their mRNA levels. Glc glucose, Glc-6-P glucose 6-phosphate, Fruc-6-P fructose 6-phosphate, Fruc-1,6-P fructose 1,6-bisphosphate, Pyr pyruvate, Lac lactate, Hk2 hexokinase 2, Pfk1 phosphofructokinase 1, Ldha lactate dehydrogenase A, Pdk1 pyruvate dehydrogenase kinase 1, PDC pyruvate dehydrogenase complex, TCA tricarboxylic acid cycle. See original reference for details [81]
Fig. 2
Fig. 2
Wnt signaling stimulates glutamine catabolism through the TCA cycle. Wnt signaling through Frizzled (Fz) and Lrp5/6 activates mTORC1 in a PI3K-Akt dependent manner; mTORC1 increases the protein abundance of glutaminase (Gls) and stimulates glutamine oxidation for ATP production. The increase in glutamine consumption results in lower intracellular glutamine levels that activate the Gcn2-Atf4 stress pathway and up-regulate the transcription of genes important for protein translation. Gln glutamine, Glu glutamate, α-KG α-ketoglutarate. See original reference for details [76, 77]

Similar articles

Cited by

References

    1. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2012;13(1):27–38. doi: 10.1038/nrm3254. - DOI - PubMed
    1. Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25:629–648. doi: 10.1146/annurev.cellbio.042308.113308. - DOI - PubMed
    1. Ducy P, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89(5):747–754. doi: 10.1016/S0092-8674(00)80257-3. - DOI - PubMed
    1. Lee B, et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet. 1997;16(3):307–310. doi: 10.1038/ng0797-307. - DOI - PubMed
    1. Komori T, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89(5):755–764. doi: 10.1016/S0092-8674(00)80258-5. - DOI - PubMed

Publication types